Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page revision label was updated from Revision: v3.6.4 to Revision: v3.6.5. This signals a minor update to the page content or underlying platform, rather than a major user-facing change.
    Difference
    0.1%
    Check dated 2026-08-08T23:34:17.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, reflecting a new page version without changing substantive content.
    Difference
    0.1%
    Check dated 2026-07-25T17:05:25.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3, signaling a minor update to the ClinicalTrials.gov record. This change reflects a backend or layout update without altering the study data or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-07-04T04:00:05.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.0 to v3.6.2, representing a minor update to the page rendering.
    Difference
    0.1%
    Check dated 2026-06-27T01:52:39.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Footer and site-wide navigation/policy elements were removed from the page, reducing the amount of footer information visible on the study record.
    Difference
    22%
    Check dated 2026-06-19T22:50:44.000Z thumbnail image
  9. Check
    74 days ago
    Change Detected
    Summary
    Recruitment status now indicates no active enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the treatment heading formatting was adjusted (Intervention/Treatment).
    Difference
    0.5%
    Check dated 2026-06-12T16:41:15.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.